Brief: Infinity Pharmaceuticals - Have Entered Into Amendment To Amended, Restated Capital On Demand Sales Agreement, Dated July 29, 2019
27/07/2021 14:32
July 27 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* INFINITY PHARMACEUTICALS - HAVE ENTERED INTO AMENDMENT TO
AMENDED, RESTATED CAPITAL ON DEMAND SALES AGREEMENT, DATED JULY
29, 2019
* INFINITY PHARMACEUTICALS INC - AMENDMENT TO INCREASE
MAXIMUM
AGGREGATE OFFERING PRICE OF SHARES OF COMMON STOCK
* INFINITY PHARMACEUTICALS- PROSPECTUS SUPPLEMENT RELATES TO
$75
MILLION OF ADDITIONAL SHARES OF COMMON STOCK THAT MAY ISSUE AND
SELL FROM TIME TO TIME
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX